GO:0006720 isoprenoid metabolic process: Biosynthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006720 (isoprenoid metabolic process) describes all chemical reactions and pathways involving isoprene-derived compounds, including the MVA and MEP routes for isoprenoid synthesis.
• The mevalonate (MVA) pathway supplies precursors for sterols, dolichols, ubiquinone, heme A, and prenylated proteins, while the MEP pathway operates in plastids of plants and many bacteria.
• Protein prenylation (farnesylation and geranylgeranylation) is a key isoprenoid-dependent modification that controls membrane targeting and function of RAS-family and other proteins.
• Dysregulation of isoprenoid metabolism is linked to cancer, cardiovascular disease, and infectious disease, making pathway enzymes attractive drug targets.
• Metabolic engineering of microorganisms and cyanobacteria enables sustainable production of isoprenoids for pharmaceuticals and biofuels.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential for dissecting isoprenoid enzyme function and pathway regulation.
Description
Isoprenoid metabolic process (GO:0006720) encompasses the chemical reactions and pathways involving isoprenoid compounds, which are built from the five-carbon isoprene unit (2-methylbuta-1,3-diene) or its derivatives. These molecules are among the most structurally diverse natural products and include sterols, carotenoids, prenylated proteins, dolichols, ubiquinones, and plant hormones. The pathway is fundamental to all domains of life, providing essential membrane components, electron carriers, and signaling molecules. In plants, isoprenoid metabolism occurs in two compartments: the cytosolic mevalonate (MVA) pathway and the plastidial methylerythritol phosphate (MEP) pathway. In bacteria such as Mycobacterium marinum, the MVA pathway supports metabolic flexibility and survival. In animals, the MVA pathway is the sole route for cholesterol and prenyl donor biosynthesis. Researchers study GO:0006720 to understand how cells allocate carbon flux, how prenylation regulates signaling proteins, and how pathway engineering can produce high-value isoprenoids. The term is also central to drug discovery, as statins and bisphosphonates target isoprenoid enzymes.
isoprenoid metabolic process At A Glance
| GO ID | GO:0006720 |
|---|---|
| GO term | isoprenoid metabolic process |
| Ontology | biological_process |
| Synonym | isoprenoid metabolism; polyisoprenoid metabolic process; polyisoprenoid metabolism; polyterpene metabolic process; polyterpene metabolism |
| Major function | Biosynthesis and interconversion of isoprene-derived compounds including sterols, prenyl diphosphates, carotenoids, and prenylated proteins |
| Key pathways | Mevalonate (MVA) pathway and methylerythritol phosphate (MEP) pathway |
| Cellular locations | Cytosol, endoplasmic reticulum, peroxisomes, plastids, and mitochondria |
| Representative enzymes | HMGCR, MVK, FDPS, GGPS1, and prenyltransferases |
| Disease relevance | Cancer, cardiovascular disease, infectious disease, and metabolic disorders |
What Is GO:0006720?
GO:0006720 is defined by QuickGO as the chemical reactions and pathways involving isoprenoid compounds, isoprene (2-methylbuta-1,3-diene), or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues. In practice, this includes the biosynthesis, interconversion, and utilization of molecules built from C5 isoprene units, such as farnesyl diphosphate, geranylgeranyl diphosphate, cholesterol, carotenoids, and prenylated proteins.
Why Is isoprenoid metabolic process Important in Cell Biology?
Isoprenoid metabolic process is essential because it produces the building blocks for cholesterol, steroid hormones, vitamin K, ubiquinone, dolichol, heme A, and the prenyl groups that modify hundreds of proteins. Protein prenylation, particularly farnesylation and geranylgeranylation, is required for the membrane association and function of RAS, RHO, and RAB GTPases, which control cell growth, cytoskeletal dynamics, and vesicle trafficking. Consequently, mutations or pharmacological inhibition of isoprenoid enzymes have profound effects on development, immunity, and cancer progression. In plants, isoprenoids serve as hormones, pigments, and defense compounds, and in microorganisms they are exploited for industrial production of pharmaceuticals and biofuels.
• Provides the C5 isoprene units for all sterols, including cholesterol and steroid hormones.
• Generates prenyl donors (FPP, GGPP) for protein prenylation of RAS, RHO, and RAB GTPases.
• Supports production of ubiquinone, dolichol, heme A, and vitamin K, which are vital for electron transport and glycosylation.
• Is a target of statins, bisphosphonates, and other drugs used to treat cardiovascular disease and bone disorders.
• Plays a central role in cancer biology through prenylated oncoproteins such as mutant RAS.
• Enables plant synthesis of carotenoids, gibberellins, and defense terpenoids.
• Is exploited in metabolic engineering of bacteria, yeast, and cyanobacteria for isoprenoid production.
• Contributes to microbial pathogenesis and metabolic flexibility in Mycobacterium marinum.
• Is a model system for studying pathway compartmentalization and metabolic channeling.
What Happens During isoprenoid metabolic process?
The Mevalonate (MVA) Pathway
In simple terms: The MVA pathway is a series of enzymatic steps that convert acetyl-CoA into the universal isoprenoid building block IPP.
In the cytosol and endoplasmic reticulum, three acetyl-CoA molecules are condensed to HMG-CoA, which is reduced to mevalonate by HMG-CoA reductase (HMGCR), the rate-limiting enzyme. Mevalonate is then phosphorylated and decarboxylated to yield isopentenyl diphosphate (IPP), which is isomerized to dimethylallyl diphosphate (DMAPP). This pathway is the sole source of isoprenoids in animals and is also present in some bacteria such as Mycobacterium marinum, where it supports metabolic flexibility.
The Methylerythritol Phosphate (MEP) Pathway
In simple terms: The MEP pathway is an alternative route to IPP and DMAPP that operates in plant plastids and many bacteria.
The MEP pathway starts with pyruvate and glyceraldehyde-3-phosphate, which are converted to 1-deoxy-D-xylulose 5-phosphate (DXP) and then to MEP. Subsequent steps yield IPP and DMAPP, which are used for plastidial isoprenoids such as carotenoids, chlorophylls, and gibberellins. The MVA and MEP pathways are interconnected through metabolic crosstalk and exchange of intermediates.
Prenyl Diphosphate Synthesis and Chain Elongation
In simple terms: IPP and DMAPP are joined together to make longer prenyl chains like FPP and GGPP.
Prenyltransferases such as farnesyl diphosphate synthase (FDPS) and geranylgeranyl diphosphate synthase (GGPS1) catalyze head-to-tail condensations of IPP with DMAPP or its homologs to produce geranyl diphosphate (GPP), farnesyl diphosphate (FPP), and geranylgeranyl diphosphate (GGPP). These molecules serve as precursors for sterols, ubiquinone, dolichol, and protein prenylation.
Protein Prenylation
In simple terms: Prenylation attaches lipid chains to proteins so they can stick to cell membranes.
Farnesyltransferase (FTase) and geranylgeranyltransferase I/II (GGTase-I/II) covalently attach FPP or GGPP to cysteine residues in CAAX motifs or C-terminal motifs of target proteins such as RAS, RHO, and RAB. This modification is essential for membrane targeting and protein-protein interactions, and its dysregulation contributes to cancer and other diseases.
Downstream Isoprenoid Diversification
In simple terms: The basic isoprenoid units are modified into hundreds of different molecules used throughout the cell.
FPP and GGPP are converted into sterols, carotenoids, terpenoids, and other specialized metabolites by terpene synthases and modifying enzymes. In plants, these include hormones, pigments, and defense compounds. In microorganisms, engineered pathways can redirect flux toward high-value isoprenoids such as artemisinin precursors and taxadiene.
Key Genes Involved in GO:0006720 isoprenoid metabolic process
The following genes encode core enzymes and regulators of isoprenoid metabolic process across species.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGCR | Rate-limiting enzyme of the MVA pathway; converts HMG-CoA to mevalonate | Target of statins; knockout models show cholesterol synthesis defects |
| MVK | Mevalonate kinase; phosphorylates mevalonate in the MVA pathway | Mutations cause mevalonate kinase deficiency; relevant to autoinflammatory disease |
| PMVK | Phosphomevalonate kinase; converts mevalonate-5-phosphate to mevalonate-5-diphosphate | Studied for pathway flux control and inherited disorders |
| MVD | Mevalonate diphosphate decarboxylase; produces IPP from mevalonate-5-diphosphate | Key node for metabolic engineering and inhibitor development |
| FDPS | Farnesyl diphosphate synthase; synthesizes FPP and GGPP | Target of bisphosphonates; knockout affects prenylation and sterol synthesis |
| GGPS1 | Geranylgeranyl diphosphate synthase; produces GGPP | Essential for protein geranylgeranylation and carotenoid biosynthesis |
| FNTA | Farnesyltransferase alpha subunit; participates in protein farnesylation | Knockout disrupts RAS membrane targeting; cancer research |
| FNTB | Farnesyltransferase beta subunit; catalytic subunit of FTase | Target for farnesyltransferase inhibitors in cancer |
| PGGT1B | Geranylgeranyltransferase type I beta subunit | Required for geranylgeranylation of RHO and RAC; knockout affects cytoskeleton |
| RABGGTA | Rab geranylgeranyltransferase alpha subunit | Mediates geranylgeranylation of RAB GTPases; vesicle trafficking studies |
| DXS | 1-deoxy-D-xylulose-5-phosphate synthase; first enzyme of the MEP pathway | Rate-limiting for plastidial isoprenoids; plant and bacterial engineering |
| DXR | 1-deoxy-D-xylulose-5-phosphate reductoisomerase; second enzyme of MEP pathway | Target of fosmidomycin; antimicrobial and antimalarial research |
| ISPD | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase; MEP pathway | Mutations cause dystroglycanopathy; glycosylation defects |
| HMGCS1 | HMG-CoA synthase 1; synthesizes HMG-CoA in MVA pathway | Knockout reduces cholesterol synthesis; metabolic studies |
| IDI1 | Isopentenyl diphosphate isomerase 1; interconverts IPP and DMAPP | Essential for balancing isoprenoid precursors; knockout is lethal in some models |
| SQS | Squalene synthase; converts FPP to squalene for sterol synthesis | Knockout blocks cholesterol biosynthesis; drug target |
| CYP51A1 | Lanosterol 14-alpha demethylase; sterol biosynthesis | Target of azole antifungals; knockout affects sterol profile |
How Is isoprenoid metabolic process Regulated?
Isoprenoid metabolic process is regulated at multiple levels. The MVA pathway is controlled by feedback mechanisms involving sterol regulatory element-binding proteins (SREBPs) and HMGCR degradation, which respond to cellular sterol levels. In plants, the MVA and MEP pathways are coordinately regulated by developmental and environmental cues, including light and stress hormones. Protein prenylation is dynamically regulated by the availability of FPP and GGPP, as well as by the expression and activity of prenyltransferases. In Mycobacterium marinum, the MVA pathway supports metabolic flexibility under varying nutrient conditions. Metabolic engineering strategies often target these regulatory nodes to increase isoprenoid yields.
isoprenoid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMGCR | Hypercholesterolemia; statin response | Knockout and point-mutation cell lines for cholesterol flux |
| MVK | Mevalonate kinase deficiency; autoinflammation | Knock-in of patient mutations in myeloid cells |
| FNTA | RAS-driven cancers | Knockout in cancer cell lines to block farnesylation |
| PGGT1B | RHO GTPase signaling; cancer | Knockout and overexpression models for geranylgeranylation |
| ISPD | Dystroglycanopathy; glycosylation defects | Knock-in of patient mutations in muscle cells |
Cancer and Prenylated Oncoproteins
Mutant RAS proteins require farnesylation for membrane localization and oncogenic signaling, making isoprenoid metabolism a therapeutic target in cancers with RAS mutations. Inhibitors of farnesyltransferase and geranylgeranyltransferase have been explored in clinical trials, and CRISPR knockout of FNTA or PGGT1B reduces RAS-driven proliferation.
Cardiovascular Disease and Cholesterol Biosynthesis
HMGCR is the target of statins, which lower LDL cholesterol by inhibiting the MVA pathway. Rare mutations in MVA pathway genes cause hypercholesterolemia or mevalonate kinase deficiency, an autoinflammatory disorder.
Infectious Disease and Microbial Isoprenoid Pathways
The MVA pathway in Mycobacterium marinum supports metabolic flexibility and survival, and MEP pathway enzymes are essential in many bacterial pathogens, making them attractive antibiotic targets. Fosmidomycin inhibits DXR in the MEP pathway and has antimalarial activity.
Developmental and Glycosylation Disorders
Mutations in ISPD, a MEP pathway enzyme, cause dystroglycanopathy due to defective glycosylation of alpha-dystroglycan. Defects in dolichol synthesis, which depends on isoprenoid precursors, lead to congenital disorders of glycosylation.
From isoprenoid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HMGCR abolish cholesterol synthesis? | HMGCR knockout cell line |
| Does a specific MVK mutation cause autoinflammation? | MVK point-mutation knock-in in macrophages |
| Can a tagged FDPS reveal subcellular localization? | FDPS knock-in with fluorescent tag |
| Does overexpression of GGPS1 increase geranylgeranylation? | GGPS1 overexpression cell line |
| Which genes are essential for isoprenoid flux? | CRISPR library screening in isoprenoid-dependent cells |
| Can MEP pathway enzymes be targeted in bacteria? | DXR knockout in Mycobacterium marinum |
How to Study the isoprenoid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C metabolic flux analysis | Flux through MVA and MEP pathways | Quantifying pathway activity in cells and microbes |
| RNA-seq | Transcript levels of isoprenoid genes | Identifying regulatory changes under stress or drug treatment |
| Proteomics | Protein abundance and modifications | Detecting prenylated proteins and enzyme levels |
| Prenylation immunoblot | Farnesylation/geranylgeranylation status | Evaluating prenyltransferase inhibitors |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Finding new regulators of isoprenoid metabolism |
| Fluorescence microscopy | Subcellular localization of tagged enzymes | Tracking FDPS, GGPS1, or prenylated proteins |
| Enzyme activity assays | Catalytic activity of HMGCR, FDPS, etc. | Testing inhibitors and mutant enzymes |
| Metabolomics | Levels of sterols, prenyl diphosphates, and intermediates | Profiling pathway output in engineered strains |
Metabolic Flux Analysis
Isotope tracing with 13C-labeled precursors (e.g., acetate or glucose) coupled to mass spectrometry quantifies flux through the MVA and MEP pathways. This method identifies rate-limiting steps and pathway crosstalk.
Transcriptomics and Proteomics
RNA-seq and quantitative proteomics reveal expression changes in isoprenoid enzymes under different conditions, such as statin treatment or infection. These approaches help identify regulatory nodes and compensatory pathways.
Prenylation Assays
Western blotting with anti-farnesyl or anti-geranylgeranyl antibodies, or metabolic labeling with azido-prenyl analogs, detects protein prenylation status. These assays are used to evaluate prenyltransferase inhibitors and CRISPR knockouts.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate isoprenoid metabolism, including synthetic lethal interactions with statins or prenyltransferase inhibitors. Hits are validated by targeted knockout or overexpression.
How CRISPR Can Be Used to Study GO:0006720 isoprenoid metabolic process
Knockout
CRISPR knockout of isoprenoid pathway genes such as HMGCR, FDPS, or FNTA abolishes specific enzymatic steps, revealing their contribution to cholesterol synthesis, prenylation, and cell growth. Knockout cell lines are valuable for drug sensitivity testing and synthetic lethality screens.
Point Mutation
Point mutations in genes like MVK or ISPD can be introduced to model inherited disorders and to dissect catalytic residues or regulatory phosphorylation sites. These models help distinguish loss-of-function from gain-of-function effects.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous loci (e.g., FDPS, GGPS1) enables real-time tracking of enzyme localization and interaction without overexpression artifacts. Knock-in of patient mutations provides physiologically relevant disease models.
Overexpression
Overexpression of rate-limiting enzymes such as DXS or HMGCR increases flux through isoprenoid pathways, which is useful for metabolic engineering and for studying pathway capacity. Inducible overexpression systems allow temporal control of pathway activation.
How EDITGENE Supports isoprenoid metabolic process Research
Researchers studying isoprenoid metabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease, or drug response. EDITGENE provides comprehensive CRISPR-based cell model services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for isoprenoid metabolic process research.
Frequently Asked Questions About isoprenoid metabolic process
What is isoprenoid metabolic process?
Isoprenoid metabolic process (GO:0006720) is the set of chemical reactions and pathways involving isoprene-derived compounds, including the MVA and MEP pathways that produce sterols, prenyl diphosphates, and prenylated proteins.
What genes are involved in isoprenoid metabolic process?
Key genes include HMGCR, MVK, FDPS, GGPS1, FNTA, FNTB, PGGT1B, DXS, and DXR, among others.
What is the difference between the MVA and MEP pathways?
The MVA pathway operates in the cytosol and is the sole source of isoprenoids in animals, while the MEP pathway operates in plastids of plants and many bacteria.
How is isoprenoid metabolism regulated?
It is regulated by feedback mechanisms involving SREBPs, HMGCR degradation, and the availability of prenyl donors, as well as developmental and environmental cues.
What diseases are linked to isoprenoid metabolic process?
Cancer, cardiovascular disease, mevalonate kinase deficiency, dystroglycanopathy, and infectious diseases are linked to defects in this pathway.
What is protein prenylation?
Protein prenylation is the covalent attachment of farnesyl or geranylgeranyl groups to proteins, which is essential for their membrane targeting and function.
How can CRISPR be used to study isoprenoid metabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect gene function, model diseases, and identify drug targets in the pathway.
What are common methods to study isoprenoid metabolic process?
Common methods include metabolic flux analysis, RNA-seq, proteomics, prenylation assays, and CRISPR screening.
Why is isoprenoid metabolism important for cancer?
Prenylated oncoproteins such as mutant RAS require isoprenoid modifications for membrane localization and signaling, making the pathway a therapeutic target.
Can isoprenoid metabolism be engineered for production?
Yes, metabolic engineering of microorganisms and cyanobacteria enables sustainable production of isoprenoids for pharmaceuticals and biofuels.
Conclusion
Isoprenoid metabolic process (GO:0006720) is a fundamental biological pathway that produces essential molecules for membrane integrity, signaling, and energy metabolism. Its dysregulation is implicated in cancer, cardiovascular disease, and inherited disorders, and its enzymes are validated drug targets. Advances in CRISPR-based models and metabolic engineering continue to illuminate pathway regulation and enable biotechnological applications. EDITGENE provides comprehensive CRISPR services to support research on this critical pathway.
References
- 1. Vranová E et al.. 2013. Network analysis of the MVA and MEP pathways for isoprenoid synthesis.. Annu Rev Plant Biol 64:665-700 PMID: 23451776
- 2. Sweetlove LJ et al.. 2025. Non-canonical plant metabolism.. Nat Plants 11(4):696-708 PMID: 40164785
- 3. McTaggart SJ. 2006. Isoprenylated proteins.. Cell Mol Life Sci 63(3):255-67 PMID: 16378247
- 4. Jung D et al.. 2023. Regulation of protein prenylation.. Biomed Pharmacother 164:114915 PMID: 37236024
- 5. Qabar CM et al.. 2025. The mevalonate pathway of isoprenoid biosynthesis supports metabolic flexibility in Mycobacterium marinum.. J Bacteriol 207(11):e0028725 PMID: 41165411
- 6. Kirby J et al.. 2008. Metabolic engineering of microorganisms for isoprenoid production.. Nat Prod Rep 25(4):656-61 PMID: 18663389
- 7. Melis A et al.. 2024. Perspectives of cyanobacterial cell factories.. Photosynth Res 162(2-3):459-471 PMID: 37966575
- 8. Li M et al.. 2020. Recent advances of metabolic engineering strategies in natural isoprenoid production using cell factories.. Nat Prod Rep 37(1):80-99 PMID: 31073570
